DSpace Repository

Impact of introducing human immunodeficiency virus testing, treatment and care in a tuberculosis clinic in rural Kenya

Show simple item record

dc.contributor Médecins Sans Frontières, Nairobi, Kenya; National Tuberculosis Programme, Homa Bay, Kenya; Médecins Sans Frontières, Paris, France
dc.creator Huerga, H
dc.creator Spillane, H
dc.creator Guerrero, W
dc.creator Odongo, A
dc.creator Varaine, F
dc.date 2010-04-09
dc.date.accessioned 2017-01-31T07:21:50Z
dc.date.available 2017-01-31T07:21:50Z
dc.identifier Int J Tuberc Lung Dis 2010;14(5):611-5
dc.identifier 1815-7920
dc.identifier 20392355
dc.identifier http://hdl.handle.net/10144/114127
dc.identifier http://fieldresearch.msf.org/msf/handle/10144/114127
dc.identifier International Journal of Tuberculosis and Lung Disease
dc.identifier.uri http://dspace.mediu.edu.my:8181/xmlui/handle/10144/114127
dc.description SETTING: In July 2005, Médecins Sans Frontières and the Ministry of Health, Kenya, implemented an integrated tuberculosis-human immunodeficiency virus (TB-HIV) programme in western Kenya. OBJECTIVE: To evaluate the impact of an integrated TB-HIV programme on patient care and TB programme outcomes. DESIGN: Retrospective evaluation of three time periods: before (January-June 2005), shortly after (January-June 2006) and medium term after (January-December 2007) the implementation of the integrated programme. RESULTS: Respectively 79% and 91% of TB patients were HIV tested shortly and at medium term after service integration. The HIV-positive rate varied from 96% before the intervention to respectively 88% (305/347) and 74% (301/405) after. The estimated number of HIV-positive cases was respectively 303, 323 and 331 in the three periods. The proportion of patients receiving cotrimoxazole prophylaxis increased significantly from 47% (142/303) to 94% (303/323) and 86% (285/331, P < 0.05). Before the intervention, 87% (171/197) of the TB-HIV patients would have been missed when initiating antiretroviral treatment, compared to respectively 29% (60/210) and 36% (78/215) after the integration. The TB programme success rate increased from 56% (230/409) to 71% (319/447) in the third period (P < 0.05); however, there was no significant decrease in the default rate: 20% to 22% (P = 0.66) and 18% (P = 0.37). CONCLUSION: Integrated TB-HIV care has a very positive impact on the management of TB-HIV patients and on TB treatment outcomes.
dc.language en
dc.relation http://www.ncbi.nlm.nih.gov/pubmed/20392355
dc.rights Archived with thanks to The International Journal of Tuberculosis and Lung Disease : the official journal of the International Union against Tuberculosis and Lung Disease
dc.title Impact of introducing human immunodeficiency virus testing, treatment and care in a tuberculosis clinic in rural Kenya
dc.type Article


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account